Search research articles
Contact Us
Filters
Showing results (271-280 of 305) with videos related to
Page
of 31
Sort By:
Frontiers in Oncology
|
November 16, 2016
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
Jérôme Fayette, Lori Wirth, Cristina Oprean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2012
Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts
Randall J Kimple, Paul M Harari, Alexandra D Torres, et al.
The New England Journal of Medicine
|
February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
James A Bonner, Paul M Harari, Jordi Giralt, et al.
Advances in Radiation Oncology
|
September 1, 2021
Why an Increasing Number of Unmatched Residency Positions in Radiation Oncology? A Survey of Fourth-Year Medical Students
Grace C Blitzer, Akash D Parekh, Shuai Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2022
Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade
Wei Wang, Taja Lozar, Athena E Golfinos, et al.
Advances in Radiation Oncology
|
February 2, 2019
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
Stephen A Rosenberg, Lauren E Henke, Narek Shaverdian, et al.
Cancer Research
|
May 20, 2016
In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
Zachary S Morris, Emily I Guy, David M Francis, et al.
JAMA Network Open
|
June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
Nancy Y Lee, Jonathan Harris, John Kim, et al.
Cancers
|
October 14, 2023
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond
Taja Lozar, Israa Laklouk, Athena E Golfinos, et al.
Cancer
|
May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
K Kian Ang, Amy Chen, Walter J Curran, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 305) with videos related to
Sort By:
Page
of 31
Frontiers in Oncology
|
November 16, 2016
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
Jérôme Fayette, Lori Wirth, Cristina Oprean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2012
Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts
Randall J Kimple, Paul M Harari, Alexandra D Torres, et al.
The New England Journal of Medicine
|
February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
James A Bonner, Paul M Harari, Jordi Giralt, et al.
Advances in Radiation Oncology
|
September 1, 2021
Why an Increasing Number of Unmatched Residency Positions in Radiation Oncology? A Survey of Fourth-Year Medical Students
Grace C Blitzer, Akash D Parekh, Shuai Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2022
Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade
Wei Wang, Taja Lozar, Athena E Golfinos, et al.
Advances in Radiation Oncology
|
February 2, 2019
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
Stephen A Rosenberg, Lauren E Henke, Narek Shaverdian, et al.
Cancer Research
|
May 20, 2016
In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
Zachary S Morris, Emily I Guy, David M Francis, et al.
JAMA Network Open
|
June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
Nancy Y Lee, Jonathan Harris, John Kim, et al.
Cancers
|
October 14, 2023
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond
Taja Lozar, Israa Laklouk, Athena E Golfinos, et al.
Cancer
|
May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
K Kian Ang, Amy Chen, Walter J Curran, et al.
Page
of 31